IGF-1 LR3 Research: Structure and Laboratory Studies
Research only. All AVM Labs USA products are sold strictly for laboratory research. Nothing on this page is medical advice, and nothing here describes use in humans or animals.
IGF-1 LR3 is one of the most searched research proteins in the scientific literature. This guide explains it the way the laboratory literature does: its molecular structure, how it is produced and characterized, and how to read the studies that mention it.
What IGF-1 LR3 is, in laboratory terms
IGF-1 LR3 is a synthetic protein and lengthened analogue of human insulin-like growth factor 1 (IGF-1), also written as Long R3 IGF-1, LR3-IGF-1 or Long-[Arg3]-IGF-I.
It differs from native IGF-1 in two structural ways. First, it carries an arginine instead of a glutamic acid at the third position of the amino acid sequence — the “arginine 3” of its name. Second, it has an additional 13 amino acids at its N-terminus, the “long” of its name, for a total of 83 amino acids, relative to the 70 of native IGF-1.
In the published literature it is classified as a recombinant IGF-1 analog: a protein built by recombinant expression rather than by solid-phase synthesis, and studied in receptor and binding assays alongside the other members of the GH/IGF-1 axis in this catalogue — which act at different receptor classes.
Molecular structure
The reported molecular identity of IGF-1 LR3 is:
- An 83-amino-acid chain — the 70-residue mature human IGF-1 domain plus a 13-residue N-terminal extension, written in one-letter code as MFPAMPLSSLFVN. The full sequence is MFPAMPLSSLFVNGPRTLCGAELVDALQFVCGDRGFYFNKPTGYGSSSRRAPQTGIVDECCFRSCDLRRLEMYCAPLKPAKSA.
- An arginine-for-glutamate substitution at position 3. In the native IGF-1 numbering it is position 3, which is why the molecule is called Arg3.
- Three intramolecular disulfide bonds — Cys19-Cys61, Cys31-Cys74 and Cys60-Cys65 — formed between six cysteine residues.
- A molecular formula of C400H619N111O115S9 and a molecular weight of approximately 9111.5 g/mol for the recombinant free protein with its three disulfide bonds formed. Some listings report C400H625N111O115S9 and 9117.6 Da instead: that is the reduced form, with the six hydrogens the disulfide bonds remove.
- Two CAS numbers in circulation: 143045-27-6, the number listed by ChemIDplus for Long-[Arg3]-IGF-I, and 946870-92-4, also cited by suppliers.
At approximately 9111.5 Da, IGF-1 LR3 is the largest molecule in this catalogue, and that mass is the first identity check on a COA.
These are the structural facts a Certificate of Analysis verifies: the sequence, the substitution, the extension, the disulfide bonds, and the molecular weight.
How it compares to native IGF-1 and to the GHRH analogs
IGF-1 LR3 is usually discussed alongside two other entries in the GH/IGF-1 literature:
- Native IGF-1 is a 70-amino-acid protein. IGF-1 LR3 is the same 70-residue domain with an arginine at position 3 and a 13-residue N-terminal extension — 83 residues in total. The two modifications are the structural rationale reported in the literature: they sharply reduce the molecule’s affinity for the IGF-binding proteins (IGFBPs) that normally sequester IGF-1.
- The GHRH analogs in this catalogue — Sermorelin, Tesamorelin and the CJC-1295 + Ipamorelin blend — act at the GHRH receptor or at GHS-R1a, the receptor classes of the upper part of the axis. IGF-1 LR3 acts at a different receptor class, the IGF-1 receptor (IGF-1R). Our posts on Sermorelin, Tesamorelin and the CJC-1295 + Ipamorelin blend cover those entries.
Same axis, different molecules, different receptor classes. That is the comparison the literature makes.
One nuance the literature itself records: the “Long” in the name refers to the added 13 residues, not to a measured half-life — a rat study found Long-[Arg3]-IGF-I cleared faster than native IGF-1, because the binding proteins that slow the clearance of native IGF-1 bind this analog only weakly. The name describes the structure, not a measured duration.
How IGF-1 LR3 is made: recombinant expression
Unlike the short peptides in this catalogue, IGF-1 LR3 is produced by recombinant expression:
- The DNA sequence encoding the 83-residue chain is introduced into a production organism, which expresses the protein.
- The protein is purified from the production mixture.
- The three disulfide bonds must form with the correct pairing for the protein to fold in its native-like shape.
- The finished protein is characterized before it is released as a reference material.
Because the molecule is expressed rather than assembled residue by residue, the laboratory controls a different set of variables: the expression system, the folding of the chain, and the pairing of the disulfide bonds. Our post on peptide synthesis explains the solid-phase method used for the short peptides in this catalogue.
How IGF-1 LR3 is characterized: identity and purity
A research protein is not defined by its name alone. In the laboratory it is defined by analytical data, typically:
- Mass spectrometry (MS): confirms the molecular weight matches the intended sequence, including the extension, the Arg3 substitution and the three disulfide bonds. For IGF-1 LR3 the observed mass must read approximately 9111.5 Da for the folded free protein.
- High-performance liquid chromatography (HPLC): measures purity and reveals impurities, including misfolded forms.
- Certificate of Analysis (COA): the laboratory document that reports those results for a specific batch.
When comparing research materials, the COA is the document that matters: same compound, different batch, different data. Our guide on how to read a peptide COA explains what each field on that document means.
How IGF-1 LR3 is studied in the literature
Laboratory research on IGF-1 LR3 takes several forms:
- Structural studies: how the 83-residue chain folds and how the three disulfide bonds hold the structure together. The NMR structure (PDB 3LRI) is the reference for this work.
- In vitro receptor assays: measurements of binding and activation at the IGF-1 receptor in cell-based systems, where conditions are controlled and variables are isolated.
- Binding-protein assays: measurements of affinity for the IGFBPs, the defining comparison between this analog and native IGF-1 in the literature.
Stability and handling in the laboratory
Proteins are sensitive molecules, and laboratory handling reflects that: storage temperature, protection from light and moisture, freeze–thaw cycles, and how long a prepared solution remains stable. Our posts on peptide storage and stability and on refrigeration and shipping cover this in detail.
How to read an IGF-1 LR3 study
When you open a paper that mentions IGF-1 LR3, check four things first:
- What exactly was studied? The compound name, the sequence or identifier, and the source of the material.
- In what model? In vitro assay, animal model, or another setting — and what that model can and cannot show.
- At what scale? The number of samples, the controls used, and whether the result was reproduced.
- Who funded it, and where was it published? Peer review and disclosure are part of the evidence, not decoration.
Related research on this blog
- CJC-1295 + Ipamorelin Research — a GHRH analog combined with a GHS-R1a agonist, in the same axis: cjc-1295-ipamorelin-research
- Tesamorelin Research — the 44-amino-acid GHRH analog: tesamorelin-research
- Ipamorelin Research — the pentapeptide GHS-R1a agonist: ipamorelin-research
- Sermorelin Research — the 29-amino-acid GHRH analog: sermorelin-research
Glossary
- IGF-1: insulin-like growth factor 1, a 70-amino-acid protein; the parent molecule of this analog.
- IGF-1 receptor (IGF-1R): the receptor class at which IGF-1 LR3 is studied in assays.
- IGFBP: IGF-binding protein, a class of proteins that bind IGF-1; this analog’s affinity for them is a defining assay measurement.
- Recombinant expression: producing a protein by introducing its DNA sequence into a production organism.
- SPPS: solid-phase peptide synthesis, the standard laboratory method for building short peptides — not used for this recombinant protein.
- HPLC: high-performance liquid chromatography, used to measure purity.
- Mass spectrometry (MS): used to confirm molecular weight and identity.
- COA: Certificate of Analysis, the batch document reporting analytical results.
Frequently asked questions (research framing)
How is IGF-1 LR3 different from native IGF-1?
Native IGF-1 is a 70-amino-acid protein. IGF-1 LR3 is the same 70-residue domain with an arginine at position 3 instead of glutamic acid, plus a 13-residue N-terminal extension (MFPAMPLSSLFVN), for 83 residues in total and a molecular weight of approximately 9111.5 Da.
What does the extension do, structurally?
It is the “Long” of the name: 13 extra residues at the N-terminus. Together with the Arg3 substitution, it is the structural rationale reported in the literature for the analog’s sharply reduced affinity for the IGF-binding proteins.
What does a COA tell me?
It reports the analytical results — identity and purity — for one specific batch, measured by the laboratory that tested it. For IGF-1 LR3, the key identity checks are the 83-residue sequence, the Arg3 substitution, the extension, the three disulfide bonds, and the molecular weight of approximately 9111.5 Da.
Where can I learn more?
Start with the posts linked above, and read the primary literature they cite.
Research only. AVM Labs USA products are for laboratory research use only.
